The effect of magnesium sulfate infusion on reduction of pain after abdominal hysterectomy surgery under general anesthesia
Phase 1
Completed
- Conditions
- Abdominal hysterectomyMagnesium SulfatePainHysterectomyAnesthesiaAnalgesic
- Registration Number
- TCTR20160308001
- Lead Sponsor
- vice chancellor of Shahid Sadoughi university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
all patients who had undergone Abdominal hysterectomy
Exclusion Criteria
Women under age 35 and over 65 years old, patients addicted to narcotics, patients who already had pulmonary, heart and kidney disease, patients who were already allergic to magnesium sulfate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mean pain scores in immediately after surgery, 1, 2, 6 and 12 hours immediately after surgery, 1, 2, 6 and 12 hours VAS scores
- Secondary Outcome Measures
Name Time Method Mean of narcotic consumption immediately after surgery, 1, 2, 6 and 12 hours mg
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie magnesium sulfate's analgesic effects post-abdominal hysterectomy?
How does magnesium sulfate infusion compare to opioids in postoperative pain management for abdominal hysterectomy?
Are there specific biomarkers that predict analgesic response to magnesium sulfate in abdominal hysterectomy patients?
What are the potential adverse events associated with magnesium sulfate infusion during general anesthesia for abdominal hysterectomy?
What combination therapies with magnesium sulfate are being explored for enhanced postoperative pain relief in abdominal hysterectomy?